Business Wire

Xilam: 2017 Full-Year Revenue: EUR 24.4 million, up 54%

Jaa

Regulatory News:

Xilam (Paris:XIL) is announcing consolidated 2017 revenue of EUR 24.4 million, an increase of 54%. This performance is all the more impressive on the back of 40% growth in 2016.

In EUR 000   31.12.2017 (1)   31.12.2016   Change
New productions(2)   15,319   10,756   42%
Catalogue   9,017   5,083   77%
Other   62   39   59%
Revenue   24,398   15,878   54%
     

(1) unaudited data
(2) including subsidies and development

New productions: substantial progress in volume terms, very strong value growth

In 2017, Xilam delivered 63 half-hour programmes to broadcasters, compared to 51 in 2016. This volume growth of 24% demonstrates the Group’s ability to satisfy strong market demand.

With revenue of EUR 15.3 million, this growth represents a 42% increase in value terms. This solid growth is a testament to the quality of the new programmes offered by Xilam and the company’s ability to build the value of its new content. Digital platforms and television channels are now both behind the sharp rise in sales of new productions.

Catalogue: performance improving on all platforms

Catalogue revenue exceeded EUR 9 million in 2017, which is an increase of 77% compared to last year. As such, Xilam’s Catalogue division has passed another major milestone which attests to the long-term strength of its brands.

This record performance is the result of more intense competition between traditional (paid and free) TV channels and digital platforms, in which Xilam has a very strong foothold. Digital platforms now account for 40% of Catalogue revenue and 23% of total revenue.

Finally, Xilam’s YouTube catalogue garnered over 2.6 billion views in 2017, which is a 21% increase compared to last year. This growth was primarily buoyed by the global success of the Zig & Sharko series which, alongside Oggy & the Cockroaches, has become a new driver for the Group’s catalogue.

An ever-increasing international presence

Xilam’s revenue growth is also due to the extremely sharp increase in international sales, which now account for 56% of total revenue. Standing at EUR 13.8 million, international sales increased 80% compared to last year.

On the Catalogue segment, international revenue accounted for 89% of revenue in 2017. Thanks to their ability to broadcast worldwide simultaneously, digital platforms are making a major contribution to international sales growth.

Outlook for 2018: continued growth

Stepping up the pace of premium content deliveries

Xilam is now perfectly sized in terms of resources and talent to satisfy the sharp growth expected. In 2018, Xilam’s teams will be focused on the production of seven animated series. In particular, Xilam will continue with deliveries of new seasons of Oggy & the Cockroaches, the wildlife series If I were an animal, Season 2 of Magic, and Paprika.

Xilam also has a number of new series currently in production, including:

  • Mr. Magoo, which broke international pre-sale records that should lead to a very promising future;
  • Coach me if you can, an original, football-themed creation from the Xilam studio that is expected to be released worldwide and will be launched to coincide with Euro 2020;
  • Season 3 of Zig & Sharko, which has already been pre-purchased by clients that bought the previous seasons.

These series will enable Xilam to achieve its target of delivering over 70 half-hour programmes in 2018. This step-up in production is in line with the company's roadmap, which aims to deliver over 100 half-hour programmes in 2020.

Xilam’s four studios (Paris, Lyon, Angoulême and Ho-Chi-Minh City) are now fully operational and well prepared to meet this target.

Innovation and constant creativity

Other projects created in the Xilam studios will enter production in 2018.

These include The Fabulous Adventures of Prince Moka and Tiny Bad Wolf , two original creations that will afford Xilam additional growth avenues in the coming years.

New catalogue revenue streams

In 2017, Xilam announced that it had signed new merchandising contracts, such as those signed with Lansay (toys) and Nazara (mobile video games).

Additions to Xilam’s sales team and the set-up of an agent network covering 75% of the world will drive growth in this segment in 2018.

Chairman and CEO of Xilam, Marc du Pontavice, commented, “ Xilam is already the leader on the French market, and is gradually becoming one of the top-tier providers of premium content to the world’s major broadcasters and platforms. The relevance of the company’s investment strategy is evident; our catalogue is becoming stronger and stronger, with content that stimulates children’s imagination.

About Xilam

Xilam is one of Europe’s leading animation companies, producing and distributing original children’s and family entertainment content in both 2D and 3D formats across TV, film and digital media platforms.

Founded in 1995 by Marc du Pontavice, Xilam owns a catalogue of more than 2,000 animated episodes and 3 feature films including strong brands such as Oggy & the Cockroaches, Zig & Sharko, The Daltons, Rolling with the Ronks! and its first pre-school series, Paprika.

Broadcast in over 160 countries on all the major TV networks, these series are also breaking audience records on all the major digital platforms, including YouTube with over 2.6 billion views in 2017, ranking Xilam as one of the top global content providers in animation.

Xilam employs more than 400 people, including 300 artists, who are based across its four studios located in Paris, Lyon, Angoulême and Ho-Chi-Minh City in Vietnam.

Xilam is listed on Euronext Paris / Ticker: XIL / ISIN code: FR0004034072

Xilam is eligible for the PEA-PME investment scheme.

Contact information

Xilam
Marc du Pontavice – Chairman and CEO
François Bardoux – CFO
Tel: (33) 01 40 18 72 00

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

1.1 Million People Benefit from the UAE-based Big Heart Foundation’s Humanitarian Efforts in 201824.3.2019 22:21:00 EETTiedote

Humanitarian aid worth US$ 15.8 million (AED 58 million) to 1,091,000 million refugees, internally displaced and acutely disadvantaged people in 12 conflict-laden nations worldwide has been offered by The Big Heart Foundation (TBHF), a leading international humanitarian organisation based in Sharjah, UAE. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190324005019/en/ (TBHF Graphic) Operating under the leadership of Her Highness Sheikha Jawaher bint Mohammed Al Qasimi, UNHCR Eminent Advocate and TBHF Chairperson, the humanitarian non-profit operating out of Sharjah – the third largest emirate in United Arab Emirates (UAE) – has mobilised the funds to support and initiate 20 projects in collaboration with UNHCR, Doctors without Borders (Médecins Sans Frontières) in vital sectors of food security, healthcare and education. Their 2018 efforts spanned 12 countries, namely, Bangladesh, Egypt, Iraq, Jordan, Malaysia, Pakistan, Pal

SCG Chemicals Company chooses gPROMS modelling for digital design and operations22.3.2019 18:55:00 EETTiedote

Process Systems Enterprise (PSE), the Advanced Process Modelling company, today announced that it has signed a long-term agreement with SCG, one of the largest integrated petrochemical companies in South East Asia, to standardise on PSE’s gPROMS® modelling technology for digital design and operations. SCG applies advanced process models within digital design initiatives to explore the process decision space rapidly and effectively, in order to reduce uncertainty and make better, faster and safer design and operating decisions. This help them to accelerate innovation and optimise the design and operation of their process plants. Dr Suracha Udomsak, SCG’s Emerging Business Director and R&D Director, says, “at SCG Chemicals, advanced process modelling (APM) is a key element in our Digital Manufacturing platform. APM accelerates innovation by making the development workflow ‘faster, cheaper & safer’, which are key considerations for us. It is a core technology building block that enables u

Logicor Announces Results for Year Ended 31 December 201822.3.2019 17:29:00 EETTiedote

Logicor announces strong financial performance for the year ended 31 December Net Operating Income (NOI): €639 million, which represents year on year growth of 2.5%, reflecting our strategic focus on increasing occupancy and capturing market rental growth. Over 60% of NOI is generated in the key markets of the UK (26%), Northern Europe1 (21%) and France (15%). Gross Asset Value: €12.5 billion, a 3.3% increase in valuation, which reflects the strong performance of our portfolio, in particular in Northern Europe. EPRA Occupancy: 94.4%, with physical occupancy up 70 bps over the year, underpinned by strong growth in each of our three largest regions of the UK (+120 bps), Northern Europe (+110 bps) and France (+220 bps). LTV: 51%, down from 52% at year end 2017 following increases in property values. At year end, our debt to EBITDA ratio was 11.3x. Capital Structure In 2018 Logicor (rated BBB (Stable) by S&P) established a Euro Medium Term Note (‘EMTN’) programme and raised €1.8 billion of

Delticom AG/Mytyres.co.uk: Buying Great Value Tyres Online Doesn’t Mean Missing out on Professional Fitting22.3.2019 17:15:00 EETTiedote

Spring is just around the corner, and it’s time for drivers to start thinking about changing to summer tyres. However, a tyre check may show that your current summer tyres are getting old, worn out, or have visible damage, such as cracks or bumps. If this is the case, then it's time for a new set of tyres. The legal minimum tread depth is 1.6 mm, however experts recommend significantly more – summer tyres should be replaced even if the tread depth is 3 mm. Regardless of mileage, you should change your tyres at least every eight to ten years. This is because the rubber starts to harden, the tyres lose grip on the road, and driving performance is affected. Of course, a set of four new tyres is a significant investment – authorised workshops can often charge between 250 and 350 pounds. If you want to save money, consider the alternatives: the result is an increasing number of customers turning to online shops such as Mytyres.co.uk to buy new tyres. The market share of tyres sold online ha

Trueman Man Clinic Achieves 10000 Surgery Milestone with Its SWITCH Operation22.3.2019 16:00:00 EETTiedote

Trueman Man Clinic Network announced that the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation), has been successfully completed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190322005013/en/ Trueman Man Clinic Network has been successfully completed the 10,000th surgery utilizing its SWITCH Premature Ejaculation Surgery (Nerve Conservation). The SWITCH Premature Ejaculation Surgery (SWITCH operation) developed in 2010 by Dr. Yang, the chief director of the Trueman Man Clinic Network, can reduce the side effects of penile neurectomy and maintain the stable reduction of the glans sensation. The Trueman Man Clinic Network is the leading hospitals for male enhancement surgeries in Korea consists of 11 clinics, with 16 doctors working. As of 2019, more than 43,000 man clinic surgeries have been performed. (Photo: Business Wire) The Trueman Man Clinic Network is the leading hospitals for m

Janssen Seeks Expanded Use of DARZALEX®▼ (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible22.3.2019 14:22:00 EETTiedote

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a Type II variation application to the European Medicines Agency (EMA) for DARZALEX®▼ (daratumumab) in combination with lenalidomide and dexamethasone (Rd) for the treatment of patients newly diagnosed with multiple myeloma who are ineligible for autologous stem cell transplant (ASCT). “Today’s submission brings us one step closer to our goal of improving treatment outcomes for people newly diagnosed with multiple myeloma,” said José Antonio Burón Vidal, VP Medical Affairs, Europe, Middle East and Africa (EMEA), Janssen-Cilag Limited. “We are incredibly grateful to the patients and investigators who participated in the MAIA clinical trial programme and look forward to working closely with the regulatory authorities to secure approval of this new combination.” The submission is supported by data from the Phase 3 MAIA (MMY3008) study, which were presented at the 60th Annual Meeting of the American

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme